schliessen

Filtern

 

Bibliotheken

Vitamin B12 levels in familial Mediterranean fever patients treated with colchicine

Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disease characterised by paroxysmal attacks of serosal inflammation. Colchicine is highly effective in preventing these attacks but it may also disrupt the intestinal absorption of vitamin B12. We hypothesised that patient... Full description

Journal Title: Clinical and experimental rheumatology 2013, Vol.31(3 Suppl 77), pp.57-9
Main Author: Gemici, Ali Ihsan
Other Authors: Sevindik, Ömür Gökmen , Akar, Servet , Tunca, Mehmet
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 0392-856X ; PMID: 24064015 Version:1
Link: http://pubmed.gov/24064015
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: medline24064015
title: Vitamin B12 levels in familial Mediterranean fever patients treated with colchicine
format: Article
creator:
  • Gemici, Ali Ihsan
  • Sevindik, Ömür Gökmen
  • Akar, Servet
  • Tunca, Mehmet
subjects:
  • Colchicine -- Therapeutic Use
  • Familial Mediterranean Fever -- Drug Therapy
  • Immunosuppressive Agents -- Therapeutic Use
  • Vitamin B 12 -- Blood
  • Vitamin B 12 Deficiency -- Blood
ispartof: Clinical and experimental rheumatology, 2013, Vol.31(3 Suppl 77), pp.57-9
description: Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disease characterised by paroxysmal attacks of serosal inflammation. Colchicine is highly effective in preventing these attacks but it may also disrupt the intestinal absorption of vitamin B12. We hypothesised that patients treated with colchicine for a prolonged period could develop deficiency of the vitamin. Ninety-five adult FMF patients on regular colchicine treatment for at least 2 years and age and sex-matched 90 healthy controls were enrolled and complete blood count with platelets, vitamin B12 and folic acid were measured in each person. We also investigated 15 adult FMF patients who were not yet on colchicine. The mean vitamin B12 values were not significantly different between the groups (352.12 (SD=171.62) pg/mL vs. 360.96 (SD=146.53) pg/mL, p=0.71), but there were significantly more vitamin B12 deficient cases among FMF patients (12 vs. 3; p=0.021) and 3 out of these 12 had megaloblastic anaemia. None of the vitamin B12 deficient controls had anaemia. We could not identify any disorder which might have causative effect for the deficiency among this subgroup. The mean vitamin B12 value of 15 colchicine-naïve cases was not significantly different from patients on colchicine (p=0.356). We did not observe significant vitamin B12 deficiency among colchicine-treated FMF patients but some cases may be more prone to developing this potentially serious disorder.
language: eng
source:
identifier: ISSN: 0392-856X ; PMID: 24064015 Version:1
fulltext: fulltext
issn:
  • 0392856X
  • 0392-856X
url: Link


@attributes
ID845344860
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid24064015
sourceidmedline
recordidTN_medline24064015
sourceformatXML
sourcesystemPC
pqid1444390128
display
typearticle
titleVitamin B12 levels in familial Mediterranean fever patients treated with colchicine
creatorGemici, Ali Ihsan ; Sevindik, Ömür Gökmen ; Akar, Servet ; Tunca, Mehmet
ispartofClinical and experimental rheumatology, 2013, Vol.31(3 Suppl 77), pp.57-9
identifierISSN: 0392-856X ; PMID: 24064015 Version:1
subjectColchicine -- Therapeutic Use ; Familial Mediterranean Fever -- Drug Therapy ; Immunosuppressive Agents -- Therapeutic Use ; Vitamin B 12 -- Blood ; Vitamin B 12 Deficiency -- Blood
descriptionFamilial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disease characterised by paroxysmal attacks of serosal inflammation. Colchicine is highly effective in preventing these attacks but it may also disrupt the intestinal absorption of vitamin B12. We hypothesised that patients treated with colchicine for a prolonged period could develop deficiency of the vitamin. Ninety-five adult FMF patients on regular colchicine treatment for at least 2 years and age and sex-matched 90 healthy controls were enrolled and complete blood count with platelets, vitamin B12 and folic acid were measured in each person. We also investigated 15 adult FMF patients who were not yet on colchicine. The mean vitamin B12 values were not significantly different between the groups (352.12 (SD=171.62) pg/mL vs. 360.96 (SD=146.53) pg/mL, p=0.71), but there were significantly more vitamin B12 deficient cases among FMF patients (12 vs. 3; p=0.021) and 3 out of these 12 had megaloblastic anaemia. None of the vitamin B12 deficient controls had anaemia. We could not identify any disorder which might have causative effect for the deficiency among this subgroup. The mean vitamin B12 value of 15 colchicine-naïve cases was not significantly different from patients on colchicine (p=0.356). We did not observe significant vitamin B12 deficiency among colchicine-treated FMF patients but some cases may be more prone to developing this potentially serious disorder.
languageeng
source
version2
lds50peer_reviewed
links
openurl$$Topenurl_article
backlink$$Uhttp://pubmed.gov/24064015$$EView_this_record_in_MEDLINE/PubMed
openurlfulltext$$Topenurlfull_article
addlink$$Uhttp://exlibris-pub.s3.amazonaws.com/aboutMedline.html$$EView_the_MEDLINE/PubMed_Copyright_Statement
search
creatorcontrib
0Gemici, Ali Ihsan
1Sevindik, Ömür Gökmen
2Akar, Servet
3Tunca, Mehmet
titleVitamin B12 levels in familial Mediterranean fever patients treated with colchicine
description
0Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disease characterised by paroxysmal attacks of serosal inflammation. Colchicine is highly effective in preventing these attacks but it may also disrupt the intestinal absorption of vitamin B12. We hypothesised that patients treated with colchicine for a prolonged period could develop deficiency of the vitamin.
1Ninety-five adult FMF patients on regular colchicine treatment for at least 2 years and age and sex-matched 90 healthy controls were enrolled and complete blood count with platelets, vitamin B12 and folic acid were measured in each person. We also investigated 15 adult FMF patients who were not yet on colchicine.
2The mean vitamin B12 values were not significantly different between the groups (352.12 (SD=171.62) pg/mL vs. 360.96 (SD=146.53) pg/mL, p=0.71), but there were significantly more vitamin B12 deficient cases among FMF patients (12 vs. 3; p=0.021) and 3 out of these 12 had megaloblastic anaemia. None of the vitamin B12 deficient controls had anaemia. We could not identify any disorder which might have causative effect for the deficiency among this subgroup. The mean vitamin B12 value of 15 colchicine-naïve cases was not significantly different from patients on colchicine (p=0.356).
3We did not observe significant vitamin B12 deficiency among colchicine-treated FMF patients but some cases may be more prone to developing this potentially serious disorder.
subject
0Colchicine -- Therapeutic Use
1Familial Mediterranean Fever -- Drug Therapy
2Immunosuppressive Agents -- Therapeutic Use
3Vitamin B 12 -- Blood
4Vitamin B 12 Deficiency -- Blood
general
024064015
1English
2MEDLINE/PubMed (U.S. National Library of Medicine)
3MEDLINE/PubMed (NLM)
sourceidmedline
recordidmedline24064015
issn
00392856X
10392-856X
rsrctypearticle
creationdate2013 May-Jun
addtitleClinical and experimental rheumatology
searchscope
0medline
1nlm_medline
2MEDLINE
scope
0medline
1nlm_medline
2MEDLINE
citationpf 57 vol 31 issue 3 Suppl 77
startdate20130101
enddate20131231
lsr30VSR-Enriched:[pqid]
sort
titleVitamin B12 levels in familial Mediterranean fever patients treated with colchicine
authorGemici, Ali Ihsan ; Sevindik, Ömür Gökmen ; Akar, Servet ; Tunca, Mehmet
creationdate20130000
lso0120130000
facets
frbrgroupid6122281091897583538
frbrtype5
newrecords20190701
languageeng
creationdate2013
topic
0Colchicine–Therapeutic Use
1Familial Mediterranean Fever–Drug Therapy
2Immunosuppressive Agents–Therapeutic Use
3Vitamin B 12–Blood
4Vitamin B 12 Deficiency–Blood
collectionMEDLINE/PubMed (NLM)
prefilterarticles
rsrctypearticles
creatorcontrib
0Gemici, Ali Ihsan
1Sevindik, Ömür Gökmen
2Akar, Servet
3Tunca, Mehmet
jtitleClinical And Experimental Rheumatology
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Gemici
1Sevindik
2Akar
3Tunca
aufirst
0Ali Ihsan
1Ömür Gökmen
2Servet
3Mehmet
au
0Gemici, Ali Ihsan
1Sevindik, Ömür Gökmen
2Akar, Servet
3Tunca, Mehmet
atitleVitamin B12 levels in familial Mediterranean fever patients treated with colchicine
jtitleClinical and experimental rheumatology
date2013
risdate2013
volume31
issue3 Suppl 77
spage57
pages57-9
issn0392-856X
formatjournal
genrearticle
ristypeJOUR
abstractFamilial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disease characterised by paroxysmal attacks of serosal inflammation. Colchicine is highly effective in preventing these attacks but it may also disrupt the intestinal absorption of vitamin B12. We hypothesised that patients treated with colchicine for a prolonged period could develop deficiency of the vitamin.
pmid24064015